The relationship among central obesity, systemic inflammation, and left ventricular diastolic dysfunction as determined by structural equation modeling

Obesity

Volumn 20, Issue 4, 2012, Pages 730-737

  Wu, Cho Kai ^a,b,c   Yang, Chung Yi ^a   Lin, Jou Wei ^a   Hsieh, Hung Jen ^a   Chiu, Fu Chun ^a   Chen, Jen Junn ^a   Lee, Jen Kuang ^b   Huang, Shu Wei ^b   Li, Hung Yuan ^b,c   Chiang, Fu Tien ^b   Chen, Jin Jer ^d,e   Tsai, Chia Ti ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; CENTRAL OBESITY; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; STRUCTURAL EQUATION MODELING; TISSUE DISTRIBUTION; TISSUE DOPPLER IMAGING; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; ODDS RATIO; PHYSICAL EXAMINATION; QUESTIONNAIRES; TAIWAN; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84859211161     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.30     Document Type: Article

References (36)

1. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 2004;55:373-394. (Pubitemid 38316733)
2. Vasan RS, Larson MG, Benjamin EJ et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955.
3. Ikonomidis I, Nikolaou M, Dimopoulou I et al. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome. Shock 2010;33:141-148.
4. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation 2003;107:659-663. (Pubitemid 36222587)
5. Wu CK, Luo JL, Wu XM et al. A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. Atherosclerosis 2009;205:497-502.
6. Wu CK, Luo JL, Tsai CT et al. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Pharmacogenomics J 2010;10:46-53.
7. Redfield MM, Jacobsen SJ, Burnett JC Jr et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202. (Pubitemid 36068707)
8. Wong CY, O'Moore-Sullivan T, Leano R et al. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004;110:3081-3087. (Pubitemid 39492002)
9. Ammar KA, Redfield MM, Mahoney DW et al. Central obesity: association with left ventricular dysfunction and mortality in the community. Am Heart J 2008;156:975-981.
10. Lang RM, Bierig M, Devereux RB et al.; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. (Pubitemid 41821197)
11. Whaley-Connell A, Govindarajan G, Habibi J et al. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 2007;293: E355-E363. (Pubitemid 47105951)
12. Zhou YT, Grayburn P, Karim A et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000;97: 1784-1789. (Pubitemid 30118520)
13. Deswal A, Petersen NJ, Feldman AM et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-2059. (Pubitemid 32373007)
14. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009;53:577-584.
15. Kankaanpää M, Lehto HR, Pärkkä JP et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006;91:4689-4695. (Pubitemid 44833458)
16. Malavazos AE, Corsi MM, Ermetici F et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007;17:294-302. (Pubitemid 46551684)
17. Morricone L, Malavazos AE, Coman C et al. Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Obes Res 2002;10:489-498. (Pubitemid 135686641)
18. Li HY, Wei JN, Lin MS et al. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta 2009;404:149-153.
19. Lester SJ, Tajik AJ, Nishimura RA et al. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol 2008;51:679-689. (Pubitemid 351221211)
20. Wu CK, Tsai CT, Hwang JJ et al. Renin-angiotensin system gene polymorphisms and diastolic heart failure. Eur J Clin Invest 2008;38:789-797.
21. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419. (Pubitemid 15018832)
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083. (Pubitemid 9091990)
23. Wu CK, Tsai CT, Chang YC et al. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure. J Hypertens 2009;27: 502-507.
24. Lin LY, Kuo HK, Li HY, Hwang JJ, Lin JW. Confirming a biological pathway in the metabolic syndrome-insight from the NHANES 1999-2002. Obesity (Silver Spring) 2008;16:2676-2681.
25. Hwang JJ, Li HY, Shieh GJ et al. Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women-a cross-racial validation. Nutr Metab Cardiovasc Dis 2008;18:671-677.
26. Lin CY, Chen PC, Kuo HK et al. Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey 1999-2002. Nutr Metab Cardiovasc Dis 2010;20:713-719.
27. Ommen SR, Nishimura RA, Appleton CP et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Dopplercatheterization study. Circulation 2000;102:1788-1794.
28. van der Meer RW, Rijzewijk LJ, Diamant M et al. The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 2008;29:1516-1522. (Pubitemid 351881987)
29. van der Meer RW, Hammer S, Smit JW et al. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 2007;56: 2849-2853. (Pubitemid 350223617)
30. McGavock JM, Lingvay I, Zib I et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007;116: 1170-1175. (Pubitemid 47360218)
31. Malavazos AE, Di Leo G, Secchi F et al. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 2010;105: 1831-1835.
32. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004;95:1140-1153. (Pubitemid 39648205)
33. Bryant D, Becker L, Richardson J et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-?. Circulation 1998;97:1375-1381. (Pubitemid 28182676)
34. Nagueh SF, Stetson SJ, Lakkis NM et al. Decreased expression of tumor necrosis factor-and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation 2001;103:1844-1850. (Pubitemid 32328396)
35. Kapadia SR, Yakoob K, Nader S et al. Elevated circulating levels of serum tumor necrosis factor-in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 2000;36:208-212. (Pubitemid 30466135)
36. Hoekstra T, Geleijnse JM, Schouten EG, Kok FJ, Kluft C. Relationship of C-reactive protein with components of the metabolic syndrome in normalweight and overweight elderly. Nutr Metab Cardiovasc Dis 2005;15: 270-278. (Pubitemid 41190984)